Evidence map›Paper›PMID 38827222›Full record

ArticleFrontiers in pediatrics2024

Case Report: Micafungin for treating

Carlos Javier Parramon-Teixido, Carme Garcia Esquerda, Marie Antoinette Frick, Cinzia Tripodi, Laura Gomez-Ganda, Cesar Wenceslao Ruiz-Campillo, Maria Josep Cabañas-Poy

Abstract readCase Reports
In one paragraph

Article in Frontiers in pediatrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Carlos Javier Parramon-TeixidoDepartment of Pharmacy, Vall d'Hebron University Hospital, Barcelona, Spain.
Carme Garcia EsquerdaDepartment of Pharmacy, Vall d'Hebron University Hospital, Barcelona, Spain.
Marie Antoinette FrickDivision of Infectious Diseases and Pediatric Immunology, Department of Pediatrics, Vall d'Hebron University Hospital, Barcelona, Spain.
Cinzia TripodiDepartment of Neonatology, Dr. Josep Trueta University Hospital of Girona, Girona, Spain.
Laura Gomez-GandaDepartment of Pharmacy, Vall d'Hebron University Hospital, Barcelona, Spain.
Cesar Wenceslao Ruiz-CampilloDepartment of Neonatology, Vall d'Hebron University Hospital, Barcelona, Spain.
Maria Josep Cabañas-PoyDepartment of Pharmacy, Vall d'Hebron University Hospital, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Urinary tract infections (UTIs) associated with indwelling urinary catheterization (IUC) in premature newborns (PNBs) pose a significant challenge in neonatal intensive care units (NICUs) due to the vulnerability of this population to infections and the necessity of invasive procedures. While bacterial UTIs have historically been predominant, there is a rising incidence of fungal pathogens, particularly non-

Indexed as

Candida glabratacase reportmicafunginpremature infanturinary tract infection

Identifiers

PMID38827222
PMCPMC11140041

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.